Steroid 21-hydroxylase deficiency is among the most common inborn errors of metabolism in man. Characterization of mutations in the 21-hydroxylase gene (CYP21) has permitted genetic diagnosis, facilitated by the polymerase chain reaction (PCR). The most common mutation is conversion of an A or C at nt656 to a G in the second intron causing aberrant splicing of mRNA. Homozygosity for nt656G is associated with profoundly deficient adrenal cortisol and aldosterone synthesis, secondary hypersecretion of adrenal androgens, and a severe form of congenital adrenal hyperplasia (CAH) characterized by ambiguous genitalia and/or sodium wasting in newborns. During the course of genetic analysis of CYP21 mutations in CAH families, we and others have noticed a number of relatives genotyped as nt656G homozygotes, yet showing no clinical signs of disease. A number of lines of evidence have led us to propose that the putative asymptomatic nt656G/G individuals are incorrectly typed due to dropout of one haplotype during PCR amplification of CYP21. For prenatal diagnosis, we recommend that microsatellite typing be used as a supplement to CYP21 genotyping in order to resolve ambiguities at nt656.
INTRODUCTION
Congenital adrenal hyperplasia (CAH) is a common human genetic disorder that is most often caused by a deficiency in the enzyme steroid 21-hydroxylase. Inherited defects of this enzyme lead to various degrees of impaired cortisol and aldosterone synthesis accompanied by increased androgen biosynthesis.
These abnormalities result in virilization of female fetuses, an accelerated growth rate and pseudo-precocious puberty. In the most severe ('salt wasting') form of the disease, a defect in aldosterone biosynthesis leads to an inability to conserve sodium. If left untreated, this disorder is potentially fatal.
The gene encoding 21-hydroxylase (CYP21), located on 6p21.3, and the various mutations observed in CAH have been extensively studied (see figure 1 of ref. 1) . The majority of mutations (>90%) that cause 21-hydroxylase deficiency are due to recombination between CYP21 and a highly homologous, closely linked pseudogene (CYP21P). Most of these are gene conversions in which one or more of the several mutations that normally inactivate CYP21P are instead found in CYP21 (2, 3) . The most common of these is a splicing mutation in the second intron at nt656, in which an A or C in CYP21 is replaced by G (4). This mutation activates a cryptic splice site that results in aberrant splicing of the pre-mRNA and is associated with both salt wasting and non-salt wasting ('simple virilizing') forms of the disease (5) .
PCR-based genotyping has facilitated genetic counseling of families with CAH among other diseases. During molecular analysis of 21-hydroxylase deficiency pedigrees, we have noticed a number of individuals (parents or siblings of CAH-patients) who are apparently homozygous for the splicing mutation (nt656G/G), yet do not show any signs or symptoms of disease (6, 7) . We herein describe a molecular analysis of several pedigrees with such individuals in which we found that apparent homozygosity for the nt656G mutation may result from unequal amplification ('allele dropout') of CYP21 alleles. We speculate that allele dropout may represent a common diagnostic pitfall of methods employing PCR.
RESULTS AND DISCUSSION
Screening 150 families with probands who had 21-hydroxylase deficiency detected 13 individuals who genotyped as nt656G *To whom correspondence should be addressed homozygotes, yet showed no clinical signs of CAH. We were troubled by the finding of an unusually high frequency of 'asymptomatic homozygotes' for a mutation expected to severely compromise 21-hydroxylase function.
Two categories of hypotheses might be advanced to explain these findings. First, the genetic analysis might be correct and a more complex biological explanation required. It was conceivable that asymptomatic individuals who were homozygous for nt656G were polymorphic for unidentified splice regulatory factors such that the cryptic splice site was ignored, permitting correct splicing of CYP21-21 pre-mRNA. Alternative splicing of pre-mRNA and read-through of splice sites is well documented (8, 9) . Alternatively, the genetic analysis might be artifactual, obscuring the presence of a normal allele. Therefore, we performed several experiments designed to distinguish between these possibilities.
First hypothesis: the genetic analysis is correct and a more complex biological explanation is required

Linkage analysis using microsatellite markers reveals conflicts in typing pedigrees
All the pedigrees in this study have been typed for mutations in CYP21 by at least two different methods in the different laboratories. In all cases the resulting identification of mutations were in complete agreement regardless of the typing method used. Figure 2 shows the mutations detected in several pedigrees involved in this study. These families were selected because their typing was unusual and disagreed with clinical data. In particular, all kindreds contained asymptomatic subjects who were apparently homozygous for the nt656G mutation.
Several linked microsatellite markers that flank the CYP21 locus at 6p21.3 were used to follow segregation of the mutationbearing chromosomes (Fig. 2) . The most informative of these microsatellite markers was highly polymorphic (13 alleles) and was located near the tumor necrosis factor locus (TNF), ∼450 kb away from CYP21 (10, 11) . Crossing-over between TNFa or D6S273 and CYP21 is very unlikely given the proximity of the markers (∼0.5 cM) to CYP21 (Fig. 1) , and we have not detected any such cross-overs in this or other work. Pedigree analysis showed that the microsatellite markers used were tightly linked and could be used to follow segregation of disease-causing chromosomes in pedigrees with unaffected nt656G/G individuals. Moreover, these linked microsatellite markers immediately eliminated uniparental disomy as a possible explanation for nt656G/G individuals.
Three pedigrees showed conflicts between the segregation of microsatellite markers (and other mutations) with the nt656 typing (Fig. 2 , pedigrees 'A', 'B' and 'C'). In family A, the mother (A1) types as an asymptomatic nt656G/G individual and the father (A2) as a nt656A/G heterozygote. Both parents are also heterozygous for the mutation V281L which is associated with the mild (non-classic) form of disease. Phase can be set from the affected child, A3. The unaffected paternal chromosome (haplotype 4) which carries nt656A;V281;TNFa102 is present in the unaffected daughter, A5. The maternal chromosome (haplotype 2) which is not present in the affected child, is inherited by the normal daughter. However, this haplotype types as nt656G;V281;TNFa96 in the mother, but types as nt656A;V281; TNFa96 in the normal daughter. This would suggest that the true genotype of the mother on this chromosome is nt656A;V281;TNFa96, which would be consistent with her ACTH stimulation data identifying her as a heterozygous carrier (Table 1 ; see below). In family B, no mutations can be detected in the paternal genes and the father (B2) types as homozygous nt656C (nt656C is the rarer normal allele). Southern analysis did not detect a deletion. The mother is heterozygous nt656A/G. Both sibs type as nt656G/G yet only one (B3) is affected. From the segregation of the paternal microsatellite markers it can be seen that both paternal haplotypes (3 and 4) are represented in his children B3 and B4 respectively, but in neither child is the nt656C allele detected. This indicates that one 'CYP21' allele has failed to amplify. As the expected paternal microsatellite markers are detected in both offspring, non-paternity is unlikely. Equally unlikely is a de novo mutation in nt656 in a child whose clinical status is unaffected.
In family C, similar to family B, no mutations can be detected in the paternal genes and the mother types as homozygous nt656G, although she is unaffected. Both sibs type as nt656G/G yet only one (C3, from the known father) is affected. Although it is possible that the affected individual has a de novo mutation in nt656, it is unlikely such a mutation would appear in the unaffected mother or half-brother. This strongly suggests that one CYP21 allele has failed to amplify.
In each of these three families, one chromosome types differently at nt656 in the parent and the unaffected child (chromosome 2 in family A, chromosome 4 in family B, chromosome 3 in family C). Therefore, it is unlikely that the nt656G/G or nt656C/C individual is a true homozygote, and more likely that one CYP21 allele has failed to amplify.
Excessively high frequency of apparent homozygosity for nt656G
In a family with an autosomal recessive disease such as CAH, each parent is presumed to be an obligate heterozygote, except in rare cases [∼1% of affected alleles (5)] of de novo mutations. Thus, the two parental alleles not inherited by the proband are presumably a representative sample of normal alleles in the population (12) . The frequency of the nt656G allele has been (24) . The 21-hydroxylase genes are located within the HLA class III genes which lie between the class I and class II at 6p21.3. The two 21-hydroxylase genes are tandemly arranged, each adjacent to the duplicated genes for the fourth component of complement C4A and C4B. (B) The position of PCR primers used for gene-specific amplifications and location of the nine gene conversions (and one mutation, P453S) that cause inactivation of the CYP21 gene (2, 3, 11, 25) . The boxes represent the exons, and darkened areas regions of sequence difference between CYP21 and CYP21P. Primers that are CYP specific are prefixed 'a' and those that hybridize to both CYP21 and CYP21P 'ab'. The suffix R denotes an antisense primer. directly studied in a random group of 80 healthy blood donors, and found to be 0.006 (13) . Moreover, this measured allele frequency is of the same order of magnitude as the estimate derived from the disease frequency, which is known from neonatal screening to be 1:14 000 live births (14) . Since 21-hydroxylase deficiency is a recessive disorder, the allele frequency is the square root of the disease frequency, or 1:120 (0.008). This value multiplied by the proportion of mutant alleles that carry nt656G [0.20-0.25, (5, 15) ], estimates the frequency of nt656G in the general population as 0.002. In contrast, our data in families of CAH patients suggest an allele frequency of 0.06 (14/228) for nt656G on the alleles not shared with the proband, representing alleles in the general population. The difference between these estimates of allele frequency [using the higher 0.006 frequency (13) versus 0.06 observed in our families] is statistically significant (P = 0.021). This statistical result makes it unlikely that the high number of apparent nt656G alleles is due to chance, and thus implausible that this many nt656G homozygotes should exist among first degree relatives of previously ascertained patients.
The need to postulate a combination of multiple rare events to satisfy the biological explanation
Fourteen asymptomatic first degree relatives were apparently homozygous for nt656G (Fig. 2) . Clinical status was inconsistent with CYP21 typing in each of four such relatives according to hormonal criteria (Table 1) . Adrenal stimulation with ACTH is the standard method for specific diagnosis of 21-hydroxylase deficiency. Cosyntropin (ACTH) tests were performed in four of the asymptomatic parents (Table 1 ). In two cases the basal serum levels of 17-OH-progesterone were slightly elevated, whereas all four basal levels of 21-deoxycortisol were in the normal range. Sixty minutes after adrenal stimulation the serum concentrations of both hormones increased to levels typical for heterozygous individuals. These results are in good agreement with the absence of any evidence of cortisol or aldosterone deficiency, or androgen excess in these individuals (16) .
Given the absence of any phenotypic evidence of disease in any of the apparently homozygous nt656G individuals, how many events would be required to explain such a phenomenon?
Initially, alternative splicing of pre-mRNA and read-through of aberrant splice sites appeared as an attractive hypothesis. However, it would also require at least one other rare event in several of the families to explain discordant genotyping results. For example, chromosome 4 in family B types differently at nt656 656 in family members B2, father and B4, healthy sib ( Fig. 1) . Assuming that family member B4 has inherited a factor(s) allowing her to circumvent the aberrant splice site, while the proband has not, it does not explain why both chromosomes 3 and 4 type differently with respect to nt656 in the children versus the father. Thus, one has to invoke de novo mutations on two different chromosomes in this family.
Recombination between the microsatellite loci and CYP21 could also be considered. However, once again, this requires two unlikely events: recombination between closely linked markers and normal splicing of mutant alleles to explain the asymptomatic nt656G/G subjects.
Another possibility would be a deletion of one CYP21 gene so that the apparently homozygous nt656G individuals were in fact hemizygous. Although hemizygosity could explain some of the discordant typing results, several considerations render this explanation implausible. First, the allele frequency of deletions (which comprise 20% of 21-hydroxylase deficiency alleles) in the general population should be similar to that for nt656G, i.e., 0.006, not 0.06 as would be the case if all dropouts in our sample were due to deletions. Second, all of the samples were screened for deletions by Southern blotting, and none were detected. CYP21 deletions can occasionally be obscured on Southern blots due to CYP21P duplications or deletions in trans, but it is extremely unlikely that this occurred in all 11 kindreds, particularly because nt656G is not known to be in linkage disequilibrium with a gene duplication or deletion. (Among 21-hydroxylase deficiency mutations, none is associated with a CYP21P deletion, only V281L is associated with duplications, and most of the subjects do not carry V281L.) Third, there are several families where the segregation is not compatible with deletions. In family A, A1 has two chromosomes amplifying, because aa281 types as heterozygous L/V with the same gene-specific priming site used for typing nt656 656 as homozygous G. In family B, both alleles 3 and 4 would need to be deleted, considering that both children B3 and B4 type as nt656G homozygous, yet B2 does not carry a homozygous deletion and indeed types as C homozygous. In family K, K1 and K3 are heterozygous at most markers except for nt656 656. Finally, even if there actually were asymptomatic nt656G hemizygotes, it would still be necessary to postulate a mechanism for lack of recognition of the abnormal splice site similar to that required to explain asymptomatic nt656G homozygotes.
Synopsis of first hypothesis
While the alternative splice hypothesis was an intriguing possibility, several lines of evidence gathered from different families have effectively eliminated this possibility. These include: (i) the finding of discrepant nt656 genotype in three families based on linkage analysis; (ii) the finding of a statistically unacceptably high frequency of asymptomatic nt656G homozygotes; and (iii) the need to postulate combinations of multiple rare events, such as de novo mutations, or CYP21 deletions which were not detected by Southern or PCR/LDR analysis.
Second hypothesis: the genetic analysis is artifactual, obscuring the presence of a normal allele PCR/LDR reveals allele dropout in typing of 21-hydroxylase deficiency pedigrees PCR coupled with ligase detection reactions (LDR) affords a powerful genetic diagnostic tool. In brief, the inactive pseudogene is excluded from amplification by using primer sets (ab71/b73R, b72/ab74R, ab71/b76R and b75/ab74R; Fig. 1 ). Specificity is conferred by CYP21-specific primer sequences at exons 3 and 6. The amplified genomic DNA is combined with a cocktail of mutant and wild-type CYP21 oligonucleotides of varied length. These oligonucleotides anneal specifically to target DNA sequences and are sealed to adjacent oligonucleotides by a thermostable ligase only when there is perfect complementarity at the ligation junction. Products of the ligation reaction are then detected by fluorescence and distinguished by size on denaturing polyacrylamide gels. Unique features of this procedure include the ability to detect multiple mutations simultaneously, and a sensitivity of better than 1% (21; Day and Barany, unpublished observations).
For almost all the families typed, we obtained identical genotypes using the PCR products generated using either the exon 3 specific primers, or the exon 6 specific primers (6) . Figure  3 illustrates a family where the different sets of PCR primers led to different apparent genotypes of a single chromosome. Note that apparent dropout in the gene-specific-PCR only occurs when amplifying across the nt656 region in the second intron. In family A, amplifications from the gene-specific priming sites in exons 3 and 6 to the start of the CYP21 gene (primers ab71/b73R and ab71/b76R) amplify the second intron and type as homozygous, whereas amplifications from the gene-specific priming sites to the 3′ end of CYP21 gene (primers b72/ab74R and b76/ab74R) which do not amplify the second intron, do not show allele dropout as evidenced by heterozygosity for V281 and L281 in the mother (A1) in contrast to the apparent homozygosity for nt656G.
Pedigree D also strongly supports the hypothesis of PCR dropout. There is discordance in the typing obtained for the affected child when amplifying from the gene-specific priming sites at exons 3 and 6 respectively. The paternal mutation in exon 4, I172N, acts as a marker for PCR dropout. Amplification from the 5′ end of CYP21 to exon 3 or exon 6 (primer pairs ab71/b73R Figure 2 . The amplification products from each CYP21 haplotype are numbered as in Figure 1 and the genotypes of subjects A1 and D3 are shown using the same conventions described in Figure 1 . The PCR products obtained from gene-specific amplifications from exon 6 and exon 3 are drawn above and below each other, respectively, and are arranged relative to the region in the CYP21 gene that they amplify. The approximate positions of amino acids V281, L281 and N172, I172 are as indicated for subjects D3 and A1 (Fig. 2) as is the position of nt656. Putative non-amplifying fragments are shown in black and are marked with a cross. In subject D3, the putative nt656A allele is paternally derived and on the same chromosome as N172 (haplotype 3). Dropout of the segment carrying nt656A also causes dropout of N172 when amplifying from exon 6, but not when amplifying from exon 3. This difference in typing occurs because the putative nt656A allele is on the same PCR fragment as N172 when amplified from exon 6, but they are on separate fragments when amplified from exon 3. In subject A1 the second mutation (L271) is 3′ of exon 6, and hence is not subject to dropout with the putative nt656A when amplifying from exon 6. and ab71/b76R) indicate the patient is nt656G/G homozygous; importantly the paternally derived mutation N172 is not detected when amplifying using primers ab71/b76R. Amplification from exon 3 to the 3′ end of CYP21 (primers b72/ab74R) allows detection of the mutation I172N. This discordance in typing from the gene-specific priming sites is not due to mutation of the gene-specific amplification sites as they appear normal when typed in the alternate amplifications (exon 6 types as normal when amplifying from exon 3 and vice versa, see Figure 3 ). Again, dropout only occurs when amplifying across the intron 2 nt656 region. Thus, the haplotype containing N172 is not detectable with primers (ab71/b76R, 5′ end of CYP21 to exon 6) but is detectable with primers b72/ab74R (exon 3 to 3′ end of CYP21) as the latter do not amplify nt656.
Possible causes of preferential allele amplification
To investigate the possibility that stable secondary structures in the amplified region were preventing one haplotype from amplifying, we methodically varied the PCR amplification conditions. Preferential amplification or allele dropout can in some instances be alleviated by altering the PCR amplification conditions such as varying (lowering) the KCl concentration (17) or by lowering the concentration of Mg 2+ ions in the PCR buffer and raising the denaturation temperature. Varying the thermocycling parameters and MgCl 2 concentration, and also including co-solvents such as formamide in the reaction mix did not alter the typing obtained when analyzing the putative asymptomatic nt656G/G individuals. Identical typings were obtained using amplifications with Taq polymerase in a KCl free buffer [50 mM Tris-HCl pH 9.2, 16 mM (NH 4 ) 2 SO 4 , 1.75 mM MgCl 2 ) or when using an alternative thermostable DNA polymerase for PCR (Stoffel polymerase; a derivative of Taq polymerase lacking the 5′-3′ exonuclease activity) with a low salt (10 mM KCl) buffer.
The possibility that dropout was occurring due to mutation of one of the gene-specific PCR priming sites as described by Day et al. (6) , was excluded by using a variety of different PCR primers (Fig. 2) . Two different gene-specific primers in exon 3 were used (b73R and b73R#2) in combination with two common primers (hybridizing to both CYP21 and CYP21P), in exon 1 (ab70) or downstream of the initiation codon in the putative TATA box (3′ end of primer at nucleotide -32; ab71); the exon 6 gene-specific primer was also used with these common primers. In all cases identical typings were obtained.
Comparative quantification of nt656 alleles by allele-specific PCR
One possibility is that allele dropout during PCR may be a consequence of amplifying relatively long fragments of CYP21, where one fragment amplifies with a lower amplification efficiency than the other. Therefore, we developed a direct quantitative allele-specific PCR amplification from nt656, which might identify a hidden normal allele (inefficiently amplifying) in the putative asymptomatic individuals. The experiment was designed such that only the CYP21 gene would be amplified due to a CYP21 specific anti-sense primer (the primer b73R differentiates CYP21 from CYP21P by way of an 8 bp deletion in exon 3 of CYP21P). The reactions were able to differentiate the nt656 alleles as the 3′ nucleotide of each forward primer was complementary to either nt656A, C or G. The resulting 3′ mismatch with the non-homologous target prevents PCR amplification. The forward primers were fluorescently 5′ labeled to allow detection and quantification of product. The product from each primer could be differentiated as the nt656G specific primer was made two nucleotides longer by the inclusion of a dAdA tail (Fig. 4) . The primers amplified a 62 nt region between nt656 and the gene-specific primer in exon 3 yielding a 101 nt product. The reactions were kept quantitative by maintaining the reactions in the exponential phase of the PCR by amplifying for 25 cycles or less. Figure 5 shows that no product was obtained from the nt656G specific primer (singly or multiplexed) from DNA of a normal individual and conversely no product is obtained from the nt656A or C specific primers when analyzing a nt656G/G patient. Our sensitive fluorescent detection should have shown the presence of a hidden allele above background. Peaks of equal height and area were obtained when the analysis was performed on a nt656A/G heterozygote showing that the experimental system was functioning as designed. All putative nt656G/G asymptomatic subjects were again typed as nt656G/G homozygous. Typing of other family members gave identical results to those obtained previously by other methods. In some cases the rarer nt656C allele was not analyzed for due to insufficient DNA being available. Thus, we have localized the causative region to within the 101 nt as this was the smallest fragment from which PCR dropout was observed (Fig. 4) .
To reduce the likelihood that stable secondary structures would form and prevent PCR amplification, genomic DNA was digested prior to the quantitative PCR analysis with PvuII, which cuts immediately 5′ and 3′ of the PCR priming sites at nt 623 and 803, (Fig. 4) . This did not alter the results.
In analogous experiments, new nt656 allelic primers were synthesized in the reverse direction, with the 3′ discriminating base as T or G for normal allele, and C for the mutant allele. Allele-specific PCR amplification was performed using a forward primer containing a CYP21-specific PCR priming site (primer b80 at the P30L gene conversion site in Fig. 1 ). This generated fluorescently labeled products of 606, 609 or 612 bp, respectively, for alleles nt656A, C or G. Using this assay gave identical typings to those obtained previously. This suggests that PCR dropout is specific to the nt656 region and is not due to mutations in PCR Figure 4 . A schematic representation of the allele specific PCR analysis of nt656. The reverse primer b73R differentiates CYP21 from CYP21P by way of a 3′ mismatch to the 8 bp deletion in exon 3 of CYP21P (black box). The three nt656 alleles (A, C and G) were differentiated by forward primers which either formed a match or mismatch at nt656 with the 3′ end of the PCR primer, thereby allowing discrimination of alleles. The product from the mutant allele, nt656G, could be differentiated from the normal alleles (nt656A or nt656C) as the PCR product incorporating the primer nt656G was 2 bp longer than that for nt656A or nt656C due to inclusion of a non-homologous 2 nt tail on the mutant primer. The allele-specific primers were 5′ labeled with the fluorescent dye 6-FAM to allow their detection and comparative quantification of product on a fluorescent DNA sequencer. The location of the PvuII sites used for restriction digestion of genomic DNA are as indicated.
priming sites in other regions of the gene, as dropout occurs when amplifying from nt656 in the forward and reverse directions, and when using different gene-specific PCR priming sites.
Dropouts of haplotypes at certain loci have been documented when using PCR to amplify and perform prenatal diagnosis from single cells (18) . However, we observed allele dropout even when starting with DNA from 1000 to 10 000 cells, and even when using highly sensitive fluorescent detection of PCR or LDR products. It has been shown that sequence dependent nucleotide mis-incorporations by Taq polymerase may mask the presence of a given haplotype (19, 20) . However, the quantitative allele-specific PCR described would not be subject to such nucleotide mis-incorporations, as the only difference between the allele specific reactions was in the last nucleotide of the allele-specific primer. All the protocols used for typing mutations in 21-hydroxylase deficiency (sequencing of PCR products, PCR/single stranded conformational polymorphisms, PCR/allele specific oligonucleotide hybridization, PCR/ligation detection reaction) utilize PCR for the initial amplification to differentiate CYP21 from CYP21P, and hence may be subject to preferential amplification (or dropout) of one haplotype.
Sequence analysis
Our hypothesis of allele dropout is further supported by the observation that sequence analysis of the intron 2 region identified several polymorphisms in some of the putative asymptomatic parents and sibs, all of which were homozygous (unpublished observations). Interestingly some normal individuals also appeared homozygous for uncommon polymorphisms Figure 5 . Comparative quantitative allele-specific PCR analysis of nt656. PCR was performed as described in Materials and Methods using primers that were specific for nt656, A, G or C alleles (Fig. 4) . When typing normal (nt656A/A) and affected (nt656G/G) individuals, only products from the homologous primers were obtained (A) and (B). Typing a heterozygous carrier (nt656G/A) gave product from both A and G primers of approximately equal amounts, indicating the assay was functioning as designed. Typing of the putative nt656G/G individuals gave identical typing of nt656G homozygous as previously obtained. Digestion with the restriction enzyme PvuII (Fig. 4) did not alter the typing obtained. The standards used for calculation of sizes were the TAMRA 350 standards which are shown in gray.
which raises the possibility that dropout may be occurring during typing of normal individuals. Comparing the number of parents typing as homozygous nt656C/C [n = 23], homozygous nt656A/A [n = 93], and heterozygous nt656A/C [n = 7] shows a significant departure from a Hardy-Weinberg distribution, strongly suggesting that a significant percentage of nt656C/C and/or nt656A/A parents are actually nt656A/C, with one allele dropped out during PCR amplification (Table 2) . Despite the potential for allele dropout, we were always able to type the proband as having CYP21 mutations on both chromosomes.
Southern analysis
The use of Southern blot analysis with a restriction enzyme that is able to differentiate the nt656 sequences (MwoI) was attempted but the large number of small fragments generated and the polymorphisms found in this region made it difficult to interpret the data (not shown). Southern blotting after digestion with either TaqI or EcoRI did not reveal any large deletion in apparent nt656G/G individuals. 
Synopsis of second hypothesis
Several lines of evidence point to a technical cause for preferential allele amplification: (i) use of different sets of PCR primers led to different apparent CYP21 genotypes for a single chromosome in one of the families; (ii) sequence analysis of the intron 2 region identified several polymorphisms in some of putative asymptomatic parents and sibs, all of which were homozygous; and (iii) the dearth of individuals heterozygous for nt656A/C also strongly suggests that a significant percentage of nt656C/C and/or nt656A/A parents are actually nt656A/C, where one allele dropped out during PCR amplification.
The reason why allele dropout should occur during the PCR is obscure. Attempts to identify the 'hidden' normal alleles in these pedigrees has so far not been possible using nucleotide specific analysis. The use of linked markers, such as the flanking microsatellites described in this work and pedigree analysis, has been the only successful means of identifying hidden alleles. The use of a PCR independent detection method may prove more successful. However, analysis of such data is complicated by the need to first distinguish the pseudogene from the active gene, as these two genes share 98% sequence identity.
In summary, these data, combined with the data discussed above negating a complex biological explanation, suggest that apparent asymptomatic nt656G/G individuals actually carry a normal functioning allele that remains undetected by all the typing methods employed because of preferential amplification of the allele carrying nt656G. For prenatal diagnosis, we recommend that microsatellite typing be used as a supplement to actual genotyping of CYP21 in order to resolve ambiguities due to this phenomenon.
Our ability to demonstrate CAH allele dropout was based on extensive genotyping of multiple polymorphisms and substantial epidemiologic and clinical information about this disease. When screening for other genetic traits, such as inherited cancers, it would be helpful to have linked polymorphisms which serve as internal controls to ensure that both chromosomes amplify.
MATERIALS AND METHODS
Patients
We studied 150 unrelated patients with the classical forms (salt wasting and simple virilizing) of CAH, their parents and siblings. All pedigrees were ascertained through presentation of an affected child. The criterion for diagnosis as an asymptomatic subject was lack of any clinical signs or symptoms of CAH.
Oligonucleotides, reagents, and standard methods for detecting mutations in CYP21
Oligonucleotide primers were synthesized on a model 394 automated DNA synthesizer (Applied Biosystems Division, Perkin-Elmer Corporation, Foster City, CA). Fluorescent label was attached to the 5′ end of oligonucleotides using 6-FAM (6-carboxyfluorescein) or 6-TET (tetrachlorinated-6-carboxyfluorescein) amidites. Thermostable DNA ligase for the ligase detection reactions (21) was purified as described (22) . Taq DNA polymerase, Stoffel fragment and other PCR reagents were obtained from the Applied Biosystems Division of Perkin-Elmer Corporation. The methods used for detection of mutations in CYP21 have been described elsewhere, and are standard in the authors' laboratories. Gene-specific PCR amplification and LDR detection was performed as described by Day et al. (6) . Allele specific oligonucleotide hybridization (ASO) was performed as described by Speiser et al. (23) . PCR products were sequenced as in Day et al. (6) or as in Schulze et al. (7) . Single stranded conformational polymorphism (SSCP) analysis of nt656 was as described (7) .
Alternative gene-specific PCR amplifications
In an attempt to amplify putative hidden haplotypes, the parameters used for gene-specific PCR amplification were varied from the standard conditions described in Day et al. (6) . The initial temperature for denaturation of the genomic DNA was varied between 94_C for 4 min, and 96_C or 98_C for 3 min. The temperature and time used for denaturation when thermal cycling was either 94_C for 1 min, 95_C for 30 s, 96_C for 30 s or as described previously. Annealing and extension was always at 72_C for 5 min unless otherwise stated, and 40 cycles of PCR were used. Amplifications with Taq DNA polymerase were performed in 25 ml of 10 mM Tris-HCl buffer, pH 8.4, containing 50 mM KCl, 5 pmol each primer, 200 mM dNTPs, 50 ng genomic DNA, 2.5 U Taq DNA polymerase and various amount of MgCl 2 . Amplifications using Stoffel fragment were performed using a low salt buffer that contained 10 instead of 50 mM KCl. The MgCl 2 concentration was varied in 0.5 mM increments from 1 to 3 mM. Amplifications using Stoffel fragment were as described (6) except the MgCl 2 concentration was varied between 2 and 5 mM in 1 mM increments. Formamide was used in the range from 0 to 5% in 1% increments with both Taq DNA polymerase and Stoffel amplification using standard conditions with 1.5 and 4 mM MgCl 2 , respectively. The sequences and locations of the primer used for gene-specific PCR are as described in Day et al. (6) .
Microsatellite PCR amplifications
The sequences of the microsatellite primers used for the amplification of loci D6S291, D6S273 and TNF have been described elsewhere (10, 24) . All the forward primers were 5′ labeled with a fluorescent dye to allow automated analysis on a fluorescent DNA sequencer. The TNF primer was labeled with the Applied Biosystemns 6-FAM dye, the D6S291 and D6S273 primers with the TET dye. PCR was performed in 25 ml of 10 mM Tris-HCl buffer, pH 8.4, containing 50 mM KCl, 1.5 mM MgCl 2 , 200 mM dNTPs, 5 pmol each primer, ∼20-50 ng of genomic DNA and 1 U Taq DNA polymerase. The DNA was initially denatured at 96_C for 3 min then thermally cycled for 40 cycles of denaturation at 95_C for 30 s, annealing at 60_C for 1 min and extension at 72_C for 30 s. The amplifications were diluted 1:50 with 10 mM Tris-HCl, pH 8.0, containing 1 mM EDTA, then a 2.5 ml sample was mixed with an equal volume of loading solution (1:5 mixture 50 mM EDTA:formamide containing 0.2% blue dextran). The sample was denatured at 80_C for 2 min then snap chilled and loaded onto a denaturing acrylamide gel (8% polyacrylamide/7 M urea gels of 0.4 mm thickness, with a well-to-read distance of 12 cm). The gel matrix was buffered with 1.2× TBE (54 mM Tris-borate and 1.2 mM EDTA, pH 8.0) and the electrophoresis chamber buffer contained 0.6× TBE (27 mM Tris-borate and 0.6 mM EDTA, pH 8.0). Electrophoresis was performed at 1200 V constant voltage and data collected using an Applied Biosystems 373 DNA sequencer running Genescan software. Sizes of amplification products were deter-mined relative to the ROX 1000 or TAMRA 350 markers by the software using the local Southern method.
Quantitative allele specific PCR detection of gene conversions at nt656
Quantitative PCR was performed using between 10 and 50 ng of genomic DNA, which in some instances had been digested with PvuII. The fluorescently labeled allele specific primers, I2AF, I2CF or I2GF (specific for nt656A, C or G, respectively) were used singly and also in combination with each other (multiplexed). The reverse primer was always b73R (6) . The PCR amplifications were performed in 25 ml of 10 mM Tris-HCl, pH 8.4, containing 50 mM KCl, 1.5 mM MgCl 2 , 200 mM dNTPs, 5 pmol each primer and 1.5 U Taq DNA polymerase. The genomic DNA was denatured at 96_C for 3 min, then cooled to 90_C for the addition of Taq DNA polymerase for a hot start. The reactions were subjected to 25 cycles of denaturation at 95_C for 30 s, annealing at 64_C for 1 min and extension at 72_C for 10 s. The polymerase activity was inhibited at the end of the reactions by the addition of 2.5 ml 50 mM EDTA. The samples were diluted between 5-and 10-fold prior to mixing with an equal volume of loading buffer and analysis on a fluorescent sequencer as described for the microsatellite amplifications.
ACTH-stimulation test and hormonal measurements
ACTH stimulation tests (25 IU ACTH intravenously) were performed with four of the clinically asymptomatic relatives with a homozygous G at nt656. Blood samples were drawn before and 60 min after the ACTH injection. The serum levels of 17-OHprogesterone and 21-deoxycortisol were measured by radioimmunoassay (Steroid laboratory Heidelberg).
